Everything below concerns Freeze-thaw. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-19. Numbers and descriptions here follow the published literature rather than marketing material.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Lyophilised cake or flake |
| Solubility class | Soluble in water and aqueous buffer | Also soluble in some polar organic solvents |
| Typical storage temperature | Minus 20 degrees Celsius or below | Desiccated and protected from light |
| Typical analytical method | LC-MS/MS | Reversed-phase separation with mass detection |
| Molecular formula | C50H69N15O9 | Free base; salt forms differ |
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
==== Glioblastoma ==== As the most aggressive cancer originated in the brain, mutations found in patients with glioblastoma are related to the deletion of a part of the extracellular domain of the epidermal growth factor receptor (EGFR). This deletion causes CBL E3 ligase unable to bind to the receptor for its recycling and degradation via a ubiquitin-lysosomal pathway. Thus, EGFR is constitutively active in the cell membrane and activates its downstream effectors that are involved in cell proliferation and migration.
==== United States ==== Baptist, Edward (2016). The Half Has Never Been Told: Slavery and the Making of American Capitalism. Basic Books. ISBN 978-0-465-09768-5. Beckert, Sven; Rockman, Seth, eds. (2016). Slavery's Capitalism: A New History of American Economic Development. University of Pennsylvania Press. ISBN 978-0-8122-2417-7. Berlin, Ira (2009). Many Thousands Gone: The First Two Centuries of Slavery in North America. Harvard University Press. ISBN 978-0-674-02082-5. Berlin, Ira; Favreau, Marc; Miller, Steven (2011). Remembering Slavery: African Americans Talk About Their Personal Experiences of Slavery and Freedom. New Press. ISBN 978-1-59558-763-3. Blackmon, Douglas A. (2012). Slavery by Another Name: The re-enslavement of black americans from the civil war to World War Two. Icon Books Limited. ISBN 978-1-84831-413-9. Boles, John B. (2015). Black Southerners, 1619–1869. University Press of Kentucky. p. 3. ISBN 978-0-8131-5786-3. Engerman, Stanley Lewis (1999). Terms of Labor: Slavery, Serfdom, and Free Labor. Stanford, CA: Stanford University Press. ISBN 978-0-8047-3521-6. Genovese, Eugene D. (2011). Roll, Jordan, Roll: The World the Slaves Made. Knopf Doubleday Publishing Group. ISBN 978-0-307-77272-5. King, Richard H.; Genovese, Eugene (1977). "Marxism and the Slave South". American Quarterly. 29 (1): 117. doi:10.2307/2712264. ISSN 0003-0678. JSTOR 2712264. Mintz, S. "Slavery Facts & Myths". Digital History. Archived from the original on November 6, 2006. Morgan, Edmund Sears (1975). American Slavery, American Freedom: The Ordeal of Colonial Virginia.
Artificial bone can be created from ceramics such as calcium phosphates (e.g. hydroxyapatite and tricalcium phosphate), Bioglass and calcium sulfate; all of which are biologically active to different degrees depending on solubility in the physiological environment. These materials can be doped with growth factors, ions such as strontium or mixed with bone marrow aspirate to increase biological activity. Some authors believe this method is inferior to autogenous bone grafting; however, infection and rejection of the graft is much less of a risk, and the mechanical properties such as Young's modulus are comparable to bone. The presence of elements such as strontium can result in higher bone mineral density and enhanced osteoblast proliferation in vivo.
== The Establishment of Institute of Biological Chemistry, Academia Sinica == Despite his significant scientific achievements, Dr. Li was also dedicated to the initiation and development of protein research in Taiwan. In spring 1958, Dr. Li was invited by Dr. Shih Hu to lecture a three-week course regarding the newly developed technology in protein chemistry and his latest pituitary gland research at National Taiwan University with the support from China Foundation for the Promotion of Education and Culture. At that time, the academic community only knew that protein research was developing rapidly abroad and a scholar had already made extraordinary achievements, and so when Dr. Li introduced the first-hand knowledge, it really attracted and inspired domestic scientists. Dr. Li believed that the protein chemistry was the foundation of future biochemical and biological sciences research, so he decided to assist the establishment of domestic protein research institute. In order to cultivate talents in Taiwan, Dr. Li personally provided scholarships and selected and persuaded scholars who have settled in Taiwan to continue the research in his or other research institutes. With the support from Academia Sinica, National Science Council, Ministry of Education, and National Taiwan University, Institute of Biological Chemistry and Institute of Biochemical Sciences, College of Life Science, National Taiwan University were established in 1972.
Sources: en.wikipedia.org
This is because the use of UV fluorescence is reagentless, or a process that does not require an added chemical to produce a reaction, with no consumables, or produces no chemical byproducts. Additionally, TAC-BIO can reliably discriminate between threat and non-threat aerosols. It was claimed to be sensitive enough to detect low concentrations, but not so sensitive that it would cause false positives. The particle-counting algorithm used in the device converted raw data into information by counting the photon pulses per unit of time from the fluorescence and scattering detectors, and comparing the value to a set threshold. The original TAC-BIO was introduced in 2010, while the second-generation TAC-BIO GEN II, was designed in 2015 to be more cost-efficient, as plastic parts were used. Its small, lightweight design allows it to be mounted to vehicles, robots, and unmanned aerial vehicles. The second-generation device could also be utilized as an environmental detector to monitor air quality in hospitals, airplanes, or even in households to detect fungus and mold.
Lady (Victoria Susan) Robey, OBE. Lately Chair, London Philharmonic Orchestra, and Founder Director, Music Masters UK. For services to Music. Shirley Denise Rogers. Director, Scottish Government. For services to Scottish Community Healthcare and to Major Events. Joanne Lucille Roney, OBE. Chief Executive, Manchester City Council. For services to Local Government. Lady (Susan Mary) Sainsbury. Philanthropist. For services to Philanthropy and to Charity. Bidesh Sarkar. Chief Financial Officer, Department for Business and Trade. For Public Service. Andrew Edward Scattergood. Chief Executive Officer, The Royal Parks. For services to Heritage and to Charity. Catriona Mary Robertson Schmolke, FREng. Chief Executive Officer, Charlie Five. For services to Engineering. Peter Leslie Shilton, OBE. For services to Association Football and to the Prevention of Gambling Harm. Kevin Sinfield, OBE. For services to Motor Neurone Disease Awareness. Elizabeth Jane Smith, MSP. Member of the Scottish Parliament for Mid Scotland and Fife. For services to Sport. Lady (Frances Mary) Sorrell, OBE. Designer and Co-Founder, Sorrell Foundation and Co-Founder and Trustee, The Saturday Club Trust. For services to Design and to the Creative Industries. Luke Staiano. Deputy Director, Ministry of Defence. For services to Defence. Ashley Tabor-King, OBE. Businessman and Founder and President of Global, the Media and Entertainment Group. For services to Media and Entertainment. Charlotte Helen Taylor. Lately Director, Antivirals and Therapeutics Taskforce, Department of Health and Social Care.
=== Cryobank === Provides long-term sample storage in liquid nitrogen. Consists of two units: one for cell lines and hybridomas, and another for mouse genetic material. The facility has automated storage systems with backup power and remote monitoring of environmental conditions. Also supplies dry ice.
Sources: en.wikipedia.org
Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.
No. Lyophilisation slows degradation rather than stopping it, and the rate depends on residual moisture, temperature and light exposure. Freezer storage extends useful life but does not make the material permanent.
A certificate is only as good as its traceability to a specific batch and a named laboratory. Documents lacking batch numbers, method descriptions or laboratory identifiers carry little weight. Confirming what was actually received generally requires a separate test of the material in hand.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.